CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v0.9.
Verdict No. 3015 · Search date 2026-09-07 · Methodology v0.9

Argentine tango or adapted-tango classes,
does it really help with Improved balance, gait, and daily activity participation in mild-to-moderate Parkinson's disease?

30-Second Summary
C
Evidence Grade C · 54 · Safety caution
Functional and participation signals for Argentine tango require separation from general dance, exercise, and social contact
Freezing of gait, postural instability, and orthostatic hypotension increase fall risk during dance. Begin with a Parkinson-experienced therapist or instructor, a stable partner, and a setting near a rail or wall; tailor turns and backward walking to ability. Tango does not replace medication or rehabilitation.
What the
research shows
Grade C with 54 points. In a 58-person three-arm trial, both tango and waltz/foxtrot improved balance, six-minute walk, and backward stride versus no intervention. A 62-person 12-month trial reported increased activity participation, but analyzed only 52 after excluding 10 who did not receive their allocation and emphasized within-group P values.
What the
ads claim
The claim that tango restores Parkinson's disease converts general dance, exercise, and social-contact effects over no intervention into a tango-specific effect.
*

Useful facts when choosing a product

  • Other ballroom dance also improved several functional outcomes.
  • The 12-month trial randomized 62 and analyzed 52.
  • Participation results were presented mainly as within-group changes.
Gap Measurement · Verdict 3015 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Partnered or adapted tango classes, generally around twice weekly, were compared with waltz/foxtrot or no intervention. Balance, gait, and activity participation were treated as separate outcomes.

02

Why this is classified as C (54)

Patient-centered function and participation and comparative trials are strengths, but the same research network, no-intervention controls, lack of masking, post-randomization exclusion, and within-group analysis give C with 54 points.

Counterpoint. Tango-specific superiority over another dance or equal-intensity exercise remains inadequately established.

Rejudgment record. Cross-check applied — Separated tango versus no intervention from another dance and incorporated 62 randomized versus 52 analyzed, within-group P values, and the same research network

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved balance, gait, and participation versus no interventionCSignals are confounded by lack of masking and general group-activity effects.
Tango-specific superiority over other dance or exerciseDAnother ballroom dance also improved outcomes and no long active-control confirmation exists.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Hackney ME·Earhart GM. 2009Three-arm randomized tango, waltz/foxtrot, and no-intervention trial13NIH and academic support; no manufacturer involvementBBS, six-minute walk, backward stride, and UPDRSBoth dances improved selected outcomes over no intervention; tango equal or superior on some measuresKey trial with another-dance active control
Study 2Twelve-month randomized tango versus no-intervention trial26NIH and academic support; overlapping research networkActivity Card Sort participationTango retention 77% to 90%, P=.006; control around 80%, P=.60; key between-group estimate not presentedLonger supporting trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-09-07).

Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson's disease: a comparison of Argentine tango and American ballroom. J Rehabil Med. 2009. PMID: 19479161. DOI: 10.2340/16501977-0362.
checked
Foster ER, Golden L, Duncan RP, Earhart GM. Community-based Argentine tango dance program is associated with increased activity participation among individuals with Parkinson's disease. Arch Phys Med Rehabil. 2013;94:240-249. PMID: 22902795. PMCID: PMC3557593. DOI: 10.1016/j.apmr.2012.07.028.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Argentine Tango for Parkinson's Disease—Better Than No Intervention, but Tango-Specific and Long-Term Effects Are Limited Evidence Grade C card
[Chamgap] Argentine Tango for Parkinson's Disease—Better Than No Intervention, but Tango-Specific and Long-Term Effects Are Limited — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/argentine-adapted-tango-parkinsons-balance-gait-participation/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.